Yazar "Yildirim, Ozge Turgay" seçeneğine göre listele
Listeleniyor 1 - 9 / 9
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Chest pain score: a novel and practical approach to angina pectoris. A diagnostic accuracy study(Associacao Paulista Medicina, 2019) Aydin, Fatih; Aksit, Ercan; Yildirim, Ozge Turgay; Aydin, Ayse Huseyinoglu; Dagtekin, Evrin; Samsa, MuratBACKGROUND: The chest pain classifications that are currently in use are based on studies that are several decades old. Various studies have indicated that these classifications are not sufficient for determining the origin of chest pain without additional diagnostic tests or tools. We describe a new chest pain scoring system that examines the relationship between chest pain and ischemic heart disease (IHD). DESIGN AND SETTING: Cross-sectional study conducted in a tertiary-level university hospital and two public hospitals. METHODS: Chest pain scores were assigned to 484 patients. These patients then underwent a treadmill stress test, followed by myocardial perfusion scintigraphy if necessary. Coronary angiography was then carried out on the patients whose tests had been interpreted as positive for ischemia. Afterwards, the relationship between myocardial ischemia and the test score results was investigated. RESULTS: The median chest pain score was 2 (range: 0-7) among the patients without IHD and 6 (1-8) among those with IHD. The median score of patients with IHD was significantly higher than that of patients without IHD (P = 0.001). Receiver operating characteristic analysis showed that the score had sensitivity of 97% and specificity of 87.5% for detecting IHD. CONCLUSION: We developed a pre-test chest pain score that uses a digital scoring system to assess whether or not the pain was caused by IHD. This scoring system can be applied easily and swiftly by healthcare professionals and can prevent the confusion that is caused by other classification and scoring systems.Öğe Comment on: Direct oral anticoagulants in adults with congenital heart disease - A single centre study(Elsevier Ireland Ltd, 2020) Yildirim, Ozge Turgay; Aydin, Fatih; Aydin, Ayse Huseyinoglu; Aksit, Ercan[Anstract Not Available]Öğe Efficacy of direct oral anticoagulants on left ventricular thrombus(Lippincott Williams & Wilkins, 2019) Yildirim, Ozge Turgay; Aksit, Ercan; Aydin, Fatih; Aydin, Ayse HuseyinogluLeft ventricular thrombus (LVT) is a commonly seen complication of myocardial infarction and it also can be seen because of hypertrophic cardiomyopathies, nonischemic dilated cardiomyopathies, malignancies, and so on. Guidelines suggest the use of warfarin for left ventricular thrombi, but recent case reports show that direct oral anticoagulants (DOACs) are beginning to be used for this complication. DOACs are strong alternatives for warfarin because of their efficacy and safety even though there is no randomized controlled trial that proves the effect of DOACs against LVT. In this article, we gather the case reports of DOACs against left ventricular thrombi in various conditions. Copyright (C) 2019 Wolters Kluwer Health, Inc. All rights reserved.Öğe Is Rivaroxaban a Safe Choice for Apical Thrombus in Atrial Fibrillation Patients? A Case Report(Elsevier Science Bv, 2018) Aydin, Fatih; Yildirim, Ozge Turgay; Aydin, Ayse Huseyinoglu; Dagtekin, Evrin; Aksit, ErcanLeft ventricular thrombi are mostly seen in the akinetic segments of left ventricle and warfarin is the golden standard treatment. In our case, a 67-year-old male patient with ischemic dilated cardiomyopathy and atrial fibrillation was under warfarin treatment, but due to fluctuations in international normalized ratio, warfarin was discontinued and changed to rivaroxaban (20 mg once a day). He had a fixed thrombus measuring 1.80 x 1.12 cm(2) in the left ventricle under warfarin treatment before rivaroxaban use. After 6 months of rivaroxaban treatment, the thrombus regressed to 1.54 x 1.06 cm(2) without any embolic episode or bleeding. This case supports the finding that rivaroxaban can be a safe alternative to warfarin when warfarin cannot be used.Öğe Red cell distribution width and its prediction value of mortality(Mosby-Elsevier, 2020) Yildirim, Ozge Turgay; Aydin, Fatih; Aydin, Ayse Huseyinoglu; Aksit, Ercan[Anstract Not Available]Öğe Short term follow-up of a patient with uncomplicated type B aortic dissection under dabigatran treatment(Turkish Soc Cardiology, 2019) Yildirim, Ozge Turgay; Canakci, Mustafa Emin; Aydin, Fatih; Aydin, Ayse Huseyinoglu; Aksit, ErcanThis case report illustrates the follow-up of a 57-year-old female with a type B aortic dissection (AD) under dabigatran treatment. The patient had been operated on 8 years earlier due to type A AD. The aortic valve was repaired and a 26-mm polyester fiber graft was applied to the ascending aorta and the aortic arch. In computerized tomography scans taken after the procedure, a dissection flap extending from the descending aorta to the iliac arteries was seen, but the patient was asymptomatic and no further surgery was performed. The patient was subsequently diagnosed with atrial fibrillation. A CHA(2)DS(2)VASc score of 3 was recorded and dabigatran treatment was initiated. The aortic aneurysm and dissection were followed up via computed tomography and echocardiography at regular intervals, and at 6 months no progression was seen. No thromboembolic or hemorrhagic events were observed. To our knowledge, this is the first case report of dabigatran treatment for a patient with a type B AD. Based on this case, the use of dabigatran would appear to be safe in a patient with an uncomplicated type B AD, but the results of this case need to be confirmed with extended follow-up and additional patients.Öğe The Crucial Importance of Optimal Primary and Secondary Prevention of Cardiovascular Disease during COVID-19 Pandemic(Taiwan Soc Cardiology, 2020) Aksit, Ercan; Gazi, Emine; Kinlmaz, Bahadir; Yildirim, Ozge Turgay; Aydin, Fatih[Anstract Not Available]Öğe The Effect of Direct Oral Anticoagulant Drugs on Platelet Indiceses and Their Relationship with Bleeding Events(2020) Aksit, Ercan; Aydin, Fatih; Yildirim, Ozge Turgay; Dagtekin, Evrin; Aydin, Ayse HuseyinogluAim: Atrial fibrillation is a common disorder and is an important cause of thromboembolic events. Recently, direct oral anticoagulant drugs (DOACs) are being used to reduce the frequency of thromboembolic events among these patients. DOACs have several advantages over oral vitamin K antagonists, such as fixed dosage and fewer side effects. However, since the drugs and their affects cannot be monitored directly, difficulties are encountered in assessing drug efficacy and side effects. For this purpose, platelet indices and their relationship with DOACs may be utilized for the prediction of thromboembolic and hemorrhagic events. Patients and Methods: 301 patients with atrial fibrillation who were using DOACs were included in the study. Platelet indices such as platelet count, platelet distribution volume, plateletcrit, platelet-large cell ratio were evaluated at the first and sixth months. The effect of DOACs on these indices and relationships with bleeding events were investigated.Results: All groups were similar in regard to baseline platelet indices, except for lower P-LCR value among recipients of rivaroxaban. When post-treatment results were compared, all groups were found to have similar values in all parameters. However, time-bound comparisons revealed that apixaban and dabigatran significantly reduced P-LCR value after 6 months of use. Conclusion: This study showed that apixaban, rivoraxaban and dabigatran had no effect on platelet count, MPV, PDW, PCT values in whole blood count of patients with non-valvular AF. All characteristics of those with and without hemorrhagic events were also similar of patients with non-valvular AF.Öğe The timing for percutaneous coronary intervention for patients with Chapman's sign(W B Saunders Co-Elsevier Inc, 2020) Yildirim, Ozge Turgay; Aydin, Fatih; Aksit, Ercan; Aydin, Aye Huseyinoglu[Anstract Not Available]
